Takeda Pharmaceuticals India Private Limited, a amalgamated foreign private limited company, was established on 01 February 2011 in Bhiwandi, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24239MH2011FTC212891. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹4.99 Cr.
Formerly known as Takeda Medicines India Private Limited. It upholds a compliant status. Employing 1 professional, Its leadership includes Anoop Kishore Kamat (Director), Rajesh Eric Dmellokamath (Director), Gopal Agrawal (Director). Past directors included Vineet Singhal, Toshikazu Ban, Anoop Kishore Kamat. Its latest AGM occurred on 09 September 2022, with the balance sheet filed on 31 March 2022. It is based at Bld. B-4, Vadapa Village, Citylink Warehousing Complex Mumbai Nash, Ik Highway, Bhiwandi, Maharashtra, 421302.
U24239MH2011FTC212891
212891
01 February 2011
₹15.00 Cr
₹4.99 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Takeda Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anoop Kishore Kamat | Director | 23 Apr 2021 | Current |
| Rajesh Eric Dmellokamath | Director | 31 Jul 2021 | Current |
| Gopal Agrawal | Director | 02 Mar 2020 | Current |
| Serina Magner Fischer | Director | 17 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
| Pramod Abcsdd | Director | 05 Apr 2012 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2021 | Past |
| Pramod Abcsdd | Director | 20 Aug 2019 | Past |
| Pramod Abcsdd | Director | 29 May 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Takeda Pharmaceuticals India Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.99% decrease. The company also saw a substantial fall in profitability, with a 43.61% decrease in profit. The company's net worth moved up by a moderate rise of 3.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Takeda Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Takeda Pharmaceuticals India has a workforce of 1 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Takeda Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Takeda Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Takeda Pharmaceuticals India Private Limited last Annual general meeting of members was held on 09 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Takeda Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was documented.
The activity Serina Magner Fischer was appointed as a Director was appointed as a Director on 17 Mar 2022 & has been associated with this company since 3 years 8 months . was completed.
The activity Rajesh Eric Dmellokamath was appointed as a Director was appointed as a Director on 31 Jul 2021 & has been associated with this company since 4 years 4 months . was completed.
Progress on Anoop Kishore Kamat was appointed as a Director was appointed as a Director on 23 Apr 2021 & has been associated with this company since 4 years 7 months . was documented.
The activity Gopal Agrawal was appointed as a Director was appointed as a Director on 02 Mar 2020 & has been associated with this company since 5 years 9 months . was completed.
Curadev: We got a new STING thing! Licensed our small molecule to boost interferon genes. #ScienceGoals #Innovation #STINGagonist.
The CIN of Takeda Pharmaceuticals India Private Limited is U24239MH2011FTC212891.
Takeda Pharmaceuticals India Private Limited is headquartered at Bld. B-4, Vadapa Village, Citylink Warehousing Complex Mumbai Nash, Ik Highway, Bhiwandi, Maharashtra, 421302.
Takeda Pharmaceuticals India Private Limited was incorporated on 01 February 2011.
The current directors of Takeda Pharmaceuticals India Private Limited are
The primary industry of Takeda Pharmaceuticals India Private Limited is Trade.
Takeda Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Takeda Pharmaceuticals India Private Limited is ₹15.00 Cr, and the paid-up capital is ₹4.99 Cr.
The compliance status of Takeda Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX